GARFIELD ALASTAIR (Chief Scientific Officer) sold 77.2% of their position (7.76K shares) of RHYTHM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $912.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 8/17/2026ACC: 0001649904-26-000013
Officer· Chief Scientific Officer
Since Feb 2026
-7.76K
Net shares
Net seller
$912.7K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
7.76K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−2.01K
Price / share
$116.11
Trade value
$233.03K
% of position
20.0%
8/13/2026
10.06K→8.05K
Common Stock
Direct
Shares
−1.56K
Price / share
$117.08
Trade value
$182.17K
% of position
19.3%
8/13/2026
8.05K→6.50K
Common Stock
Direct
Shares
−3.40K
Price / share
$118.28
Trade value
$402.17K
% of position
52.3%
8/13/2026
6.50K→3.10K
Common Stock
Direct
Shares
−800.00
Price / share
$119.17
Trade value
$95.34K
% of position
25.8%
8/13/2026
3.10K→2.29K
Total
Net shares
−7.76K
Net value
-$912.70K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/13/2026 | S · Sale | −2.01K | $116.11 | $233.03K | 20.0% | 10.06K | 8.05K |
| Common Stock Direct | 8/13/2026 | S · Sale | −1.56K | $117.08 | $182.17K | 19.3% | 8.05K | 6.50K |
| Common Stock Direct | 8/13/2026 | S · Sale | −3.40K | $118.28 | $402.17K | 52.3% | 6.50K | 3.10K |
| Common Stock Direct | 8/13/2026 | S · Sale | −800.00 | $119.17 | $95.34K | 25.8% | 3.10K | 2.29K |
| Total | −7.76K | -$912.70K | ||||||
Derivative Transactions0
No derivative transactions reported